BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gauthier G, Guérin A, Zhdanava M, Jacobson W, Nomikos G, Merikle E, François C, Perez V. Treatment patterns, healthcare resource utilization, and costs following first-line antidepressant treatment in major depressive disorder: a retrospective US claims database analysis. BMC Psychiatry 2017;17:222. [PMID: 28629442 DOI: 10.1186/s12888-017-1385-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Arnaud A, Suthoff E, Tavares RM, Zhang X, Ravindranath AJ. The Increasing Economic Burden with Additional Steps of Pharmacotherapy in Major Depressive Disorder. Pharmacoeconomics 2021;39:691-706. [PMID: 33908024 DOI: 10.1007/s40273-021-01021-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 de Witte M, Knapen A, Stams G, Moonen X, Hooren SV. Development of a music therapy micro-intervention for stress reduction. The Arts in Psychotherapy 2022;77:101872. [DOI: 10.1016/j.aip.2021.101872] [Reference Citation Analysis]
3 Fuller-tyszkiewicz M, Richardson B, Lewis V, Linardon J, Mills J, Juknaitis K, Lewis C, Coulson K, O'donnell R, Arulkadacham L, Ware A, Krug I. A randomized trial exploring mindfulness and gratitude exercises as eHealth-based micro-interventions for improving body satisfaction. Computers in Human Behavior 2019;95:58-65. [DOI: 10.1016/j.chb.2019.01.028] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
4 Kern DM, Cepeda MS, Defalco F, Etropolski M. Treatment patterns and sequences of pharmacotherapy for patients diagnosed with depression in the United States: 2014 through 2019. BMC Psychiatry 2020;20:4. [PMID: 31900133 DOI: 10.1186/s12888-019-2418-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
5 Benson C, Singer D, Carpinella CM, Shawi M, Alphs L. The Health-Related Quality of Life, Work Productivity, Healthcare Resource Utilization, and Economic Burden Associated with Levels of Suicidal Ideation Among Patients Self-Reporting Moderately Severe or Severe Major Depressive Disorder in a National Survey. Neuropsychiatr Dis Treat 2021;17:111-23. [PMID: 33500620 DOI: 10.2147/NDT.S229530] [Reference Citation Analysis]
6 Jaffe DH, Rive B, Denee TR. The burden of suicidal ideation across Europe: a cross-sectional survey in five countries. Neuropsychiatr Dis Treat 2019;15:2257-71. [PMID: 31496708 DOI: 10.2147/NDT.S204265] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
7 de Witte M, Orkibi H, Zarate R, Karkou V, Sajnani N, Malhotra B, Ho RTH, Kaimal G, Baker FA, Koch SC. From Therapeutic Factors to Mechanisms of Change in the Creative Arts Therapies: A Scoping Review. Front Psychol 2021;12:678397. [PMID: 34366998 DOI: 10.3389/fpsyg.2021.678397] [Reference Citation Analysis]
8 Ross EL, Zivin K, Maixner DF. Cost-effectiveness of Electroconvulsive Therapy vs Pharmacotherapy/Psychotherapy for Treatment-Resistant Depression in the United States. JAMA Psychiatry 2018;75:713-22. [PMID: 29800956 DOI: 10.1001/jamapsychiatry.2018.0768] [Cited by in Crossref: 47] [Cited by in F6Publishing: 33] [Article Influence: 15.7] [Reference Citation Analysis]
9 Hall M, Dobson F, Van Ginckel A, Nelligan RK, Collins NJ, Smith MD, Ross MH, Smits E, Bennell KL. Comparative effectiveness of exercise programs for psychological well-being in knee osteoarthritis: A systematic review and network meta-analysis. Semin Arthritis Rheum 2021;51:1023-32. [PMID: 34416624 DOI: 10.1016/j.semarthrit.2021.07.007] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Mésidor M, Rousseau MC, Duquette P, Sylvestre MP. Classification and visualization of longitudinal patterns of medication dose: An application to interferon-beta-1a and amitriptyline in patients with multiple sclerosis. Pharmacoepidemiol Drug Saf 2021;30:1214-23. [PMID: 34031946 DOI: 10.1002/pds.5297] [Reference Citation Analysis]
11 Yan T, Greene M, Chang E, Houle CR, Tarbox MH, Broder MS. Impact of Atypical Antipsychotics as Adjunctive Therapy on Psychiatric Cost and Utilization in Patients with Major Depressive Disorder. Clinicoecon Outcomes Res 2020;12:81-9. [PMID: 32104020 DOI: 10.2147/CEOR.S231824] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Klein NS, Wijnen BFM, Lokkerbol J, Buskens E, Elgersma HJ, van Rijsbergen GD, Slofstra C, Ormel J, Dekker J, de Jong PJ, Nolen WA, Schene AH, Hollon SD, Burger H, Bockting CLH. Cost-effectiveness, cost-utility and the budget impact of antidepressants versus preventive cognitive therapy with or without tapering of antidepressants. BJPsych Open 2019;5:e12. [PMID: 30762507 DOI: 10.1192/bjo.2018.81] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
13 Miyazaki C, Sakashita T, Jung W, Kato S. Real-World Prescription Pattern and Healthcare Cost Among Patients with Ulcerative Colitis in Japan: A Retrospective Claims Data Analysis. Adv Ther 2021;38:2229-47. [PMID: 33515423 DOI: 10.1007/s12325-020-01615-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Szabo SM, Gooch K, Schermer C, Walker D, Lozano-Ortega G, Rogula B, Deighton A, Vonesh E, Campbell N. Association between cumulative anticholinergic burden and falls and fractures in patients with overactive bladder: US-based retrospective cohort study. BMJ Open 2019;9:e026391. [PMID: 31061036 DOI: 10.1136/bmjopen-2018-026391] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 8.0] [Reference Citation Analysis]
15 Nazir S, Farooq RK, Khan H, Alam T, Javed A. Thymoquinone harbors protection against Concanavalin A-induced behavior deficit in BALB/c mice model. J Food Biochem 2021;45:e13348. [PMID: 32618005 DOI: 10.1111/jfbc.13348] [Reference Citation Analysis]
16 Kraus SR, Shiozawa A, Szabo SM, Qian C, Rogula B, Hairston J. Treatment patterns and costs among patients with OAB treated with combination oral therapy, sacral nerve stimulation, percutaneous tibial nerve stimulation, or onabotulinumtoxinA in the United States. Neurourol Urodyn 2020;39:2206-22. [PMID: 32827230 DOI: 10.1002/nau.24474] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Hsing SC, Jin YT, Tzeng NS, Chung CH, Chen TY, Chang HA, Kao YC, Chien WC. Is Agomelatine Associated with Less Sedative-Hypnotic Usage in Patients with Major Depressive Disorder? A Nationwide, Population-Based Study. Neuropsychiatr Dis Treat 2020;16:1727-36. [PMID: 32801707 DOI: 10.2147/NDT.S257723] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Gauthier G, Mucha L, Shi S, Guerin A. Economic burden of relapse/recurrence in patients with major depressive disorder. J Drug Assess 2019;8:97-103. [PMID: 31192030 DOI: 10.1080/21556660.2019.1612410] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
19 Olopoenia A, Camelo-Castillo W, Qato DM, Adekoya A, Palumbo F, Sera L, Simoni-Wastila L. Patterns of opioid and benzodiazepine use with gabapentin among disabled Medicare beneficiaries - A retrospective cohort study. Drug Alcohol Depend 2022;230:109180. [PMID: 34847506 DOI: 10.1016/j.drugalcdep.2021.109180] [Reference Citation Analysis]
20 Ross EL, Vijan S, Miller EM, Valenstein M, Zivin K. The Cost-Effectiveness of Cognitive Behavioral Therapy Versus Second-Generation Antidepressants for Initial Treatment of Major Depressive Disorder in the United States: A Decision Analytic Model. Ann Intern Med 2019;171:785-95. [PMID: 31658472 DOI: 10.7326/M18-1480] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 3.3] [Reference Citation Analysis]